MP
INSIDER · UTHR · UNITED THERAPEUTICS Corp · EVP & GENERAL COUNSEL
MAHON PAUL A
Every open-market transaction filed under this name, Aug 20 to Oct 15.
Filings
43
0 buys · 43 sells
Bought
—
open market, at cost
Sold
$21.7M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 15 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 719 | $546.56 | $393K | +3.1% |
| Oct 15 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 2,615 | $545.69 | $1.4M | +3.3% |
| Oct 15 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 791 | $544.85 | $431K | +3.4% |
| Oct 15 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 1,983 | $543.56 | $1.1M | +3.7% |
| Oct 15 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 1,924 | $542.49 | $1M | +3.9% |
| Oct 15 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 268 | $541.64 | $145K | +4.0% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 160 | $573.15 | $92K | −1.7% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 823 | $572.25 | $471K | −1.5% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 838 | $570.90 | $478K | −1.3% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 739 | $569.15 | $421K | −1.0% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 720 | $567.76 | $409K | −0.8% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 400 | $566.41 | $227K | −0.5% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 1,480 | $563.09 | $833K | +0.1% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 780 | $561.87 | $438K | +0.3% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 1,480 | $560.19 | $829K | +0.6% |
| Oct 1 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 880 | $558.30 | $491K | +0.9% |
| Sep 17 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 320 | $501.58 | $161K | +12.3% |
| Sep 17 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 125 | $500.80 | $63K | +12.5% |
| Sep 17 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 1,160 | $499.75 | $580K | +12.8% |
| Sep 17 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 843 | $498.74 | $420K | +13.0% |
| Sep 17 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 1,400 | $497.54 | $697K | +13.3% |
| Sep 17 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 2,873 | $496.58 | $1.4M | +13.5% |
| Sep 17 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 1,579 | $495.97 | $783K | +13.6% |
| Sep 3 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 320 | $490.88 | $157K | +14.8% |
| Sep 3 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 10 | $488.32 | $5K | +15.4% |
| Sep 3 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 169 | $487.36 | $82K | +15.6% |
| Sep 3 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 598 | $486.47 | $291K | +15.8% |
| Sep 3 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 954 | $485.12 | $463K | +16.2% |
| Sep 3 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 200 | $483.85 | $97K | +16.5% |
| Sep 3 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 160 | $482.66 | $77K | +16.7% |
| Sep 3 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 1,048 | $481.92 | $505K | +16.9% |
| Sep 3 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 2,360 | $480.86 | $1.1M | +17.2% |
| Sep 3 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 936 | $479.66 | $449K | +17.5% |
| Sep 3 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 1,545 | $478.93 | $740K | +17.7% |
| Aug 20 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 120 | $527.21 | $63K | +6.9% |
| Aug 20 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 400 | $526.38 | $211K | +7.0% |
| Aug 20 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 940 | $525.25 | $494K | +7.3% |
| Aug 20 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 192 | $523.69 | $101K | +7.6% |
| Aug 20 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 850 | $522.78 | $444K | +7.8% |
| Aug 20 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 787 | $522.00 | $411K | +7.9% |
| Aug 20 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 1,819 | $521.04 | $948K | +8.1% |
| Aug 20 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 502 | $520.03 | $261K | +8.4% |
| Aug 20 | UTHR | UNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | Sell | 2,690 | $524.15 | $1.4M | +7.5% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.